Advertisement
News
Subscribe to MDT Magazine News

U of South Carolina, a Leader in Ultrasound Education, Hosts World Congress in Spring

January 21, 2011 5:34 am | by Bio-Medicine.Org | Comments

COLUMBIA, S.C., Jan. 21, 2011 /PRNewswire-USNewswire/ -- It's been called the stethoscope for the 21st century. Ultrasound is a valuable tool that allows doctors to diagnose and treat patients quickly and accurately. It's been around for decades, but there has been revolutionary change in...

TOPICS:

HIG Capital to buy NovaMed for $109M

January 21, 2011 4:45 am | by The Associated Press | Comments

Ambulatory surgery center operator NovaMed Inc. said Friday it agreed to be acquired by private equity investment firm H.I.G. Capital for about $109 million.Shareholders of NovaMed, which is based in Chicago, will receive $13.25 per share in cash under the agreement. That is a x2.6 percent...

European panel recommends against MS drug Fampyra

January 21, 2011 3:45 am | by The Associated Press | Comments

A European Union committee recommended against approving Biogen Idec Inc.'s multiple sclerosis drug Fampyra, saying the drug does not help patients much and its side effects outweigh its benefits.The Committee for Medical Products for Human Use said it recommended that the drug not be approved...

Advertisement

VIVUS Provides Regulatory Update on QNEXA NDA

January 21, 2011 3:36 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Jan. 21, 2011 /- VIVUS, Inc. (Nasdaq: VVUS ) today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug Application (NDA) for QNEXA®, an investigational drug for the treatment of obesity.  The meeting...

TOPICS:

Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)

January 21, 2011 3:35 am | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, Jan. 21, 2011 /- GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion, recommending...

TOPICS:

UMC produces customer CMOS-MEMS sensor pProducts

January 20, 2011 7:41 pm | by I-Micronews | Comments

Volume production to begin this year.

STMicroelectronics and Bluechiip to cooperate in manufacturing of unique MEMS-based tracking tags

January 20, 2011 7:41 pm | by I-Micronews | Comments

ST?s world-leading MEMS bio-sensor and actuator manufacturing expertise to bring Bluechiip?s patented tracking tag concept into mass production for healthcare and a wide range of other applications.

Samsung acquires Liquavista

January 20, 2011 7:41 pm | by I-Micronews | Comments

Samsung Electronics Co. Ltd. has acquired display technology firm Liquavista BV for an undisclosed price.

Advertisement

Treating Genetic Disorders Before Birth

January 20, 2011 7:36 pm | by Massachusetts Institute of Technology | Comments

Researchers are working on transplanting stem cells in utero.

TOPICS:

Intuitive Surgical 4Q profit rises 56 percent

January 20, 2011 2:46 pm | by The Associated Press | Comments

Intuitive Surgical Inc. on Thursday said its fourth-quarter net income rose 56 percent on better sales of its minimally invasive surgical platform, da Vinci.Net income increased to $121.2 million, or $3.02 per share, from $77.5 million, or $1.95 per share, in the same period a year earlier....

Nordion has first profitable quarter since MDS restructuring, initiates dividend

January 20, 2011 2:45 pm | by The Associated Press | Comments

Nordion Inc. (TSX:NDN), an Ottawa-based company that supplies radioactive isotopes to health-care professionals around the world, says it will begin paying a dividend to shareholders. The former subsidiary of MDS Inc., which has been dismantled and sold to various buyers, posted a $15.7-milion...

Corcept publicly offering common stock

January 20, 2011 12:45 pm | by The Associated Press | Comments

Drug developer Corcept Therapeutics Inc. said Thursday it will publicly offer shares of common stock.The company did not disclose details of the offering.It will also grant underwriters a 30-day option to buy up to an additional 15 percent of the stock offered in the public offering, to cover...

Uncovering the genetics of prostate cancer

January 20, 2011 12:41 pm | by EurekAlert | Comments

(Helmholtz Association of German Research Centres) Germany will contribute another project to the International Cancer Genome Consortium. Coordinated by the German Cancer Research Center and the University Medical Center Hamburg-Eppendorf, physicians and molecular biologists will...

TOPICS:

Scientists grow human liver tissue to be used for transplantation

January 20, 2011 12:41 pm | by EurekAlert | Comments

(Wiley-Blackwell) A new study reports on the success of growing human liver cells on resorbable scaffolds made from material similar to surgical sutures. Researchers suggest that this liver tissue could be used in place of donor organs. Findings of this study appear in the February...

TOPICS:

Pervasis broadens to cancer therapeutics, eyes new financings

January 20, 2011 12:40 pm | by Mass High Tech: The Journal of New England Technology | Comments

Pervasis Therapeutics Inc., which focuses on vascular surgical treatment, is expanding its coverage into oncology and considering additional financing from either a corporate partner or the venture capital community.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading